• Is Alterity Therapeutics Limited (PBN) stock good for wealth creation - July 2025 Decliners & Advanced Technical Signal Analysis newser.com Fri, 03 Oct 2025 03:45:17 GMT
• Alterity Therapeutics to Deliver Multiple Presentations at GlobeNewswire Thu, 02 Oct 2025 11:37:05 GMT
• First Potential Treatment for MSA: Alterity's ATH434 Phase 2 Results Show Disease Progression Slowdown Stock Titan Thu, 02 Oct 2025 11:35:00 GMT
• alterity therapeutics : to deliver multiple presentations at the 2025 international congress of parkinson’s disease and movement d... MarketScreener Thu, 02 Oct 2025 01:13:05 GMT
• Alterity Therapeutics to Present Promising Phase 2 Trial Results for MSA Treatment at 2025 Congress TipRanks Wed, 01 Oct 2025 23:59:24 GMT
• Can Alterity Therapeutics Limited (PBN) stock sustain institutional flows - Recession Risk & AI Based Buy and Sell Signals newser.com Wed, 01 Oct 2025 11:43:32 GMT
• Will Alterity Therapeutics Limited (PBN) stock profit from AI boom - July 2025 Action & Weekly Top Stock Performers List newser.com Wed, 01 Oct 2025 09:16:41 GMT
• StockTake: Alterity’s ATH434 shows US$2.4b potential for treating MSA The Mercury Tue, 30 Sep 2025 19:30:30 GMT
• Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434 Yahoo Finance Tue, 30 Sep 2025 19:01:34 GMT
• Is Alterity Therapeutics Limited (PBN) stock good for wealth creation - 2025 Dividend Review & Free Accurate Trade Setup Notificat... newser.com Tue, 30 Sep 2025 05:00:35 GMT
• What valuation ratios show for Alterity Therapeutics Limited (PBN) stock - July 2025 PostEarnings & Pattern Based Trade Signal Sys... newser.com Tue, 30 Sep 2025 04:57:12 GMT
• How Alterity Therapeutics Limited (Common Stock) (PBN0) stock compares with market leaders - Quarterly Earnings Report & Fast Exit... newser.com Mon, 29 Sep 2025 22:26:36 GMT
• What valuation ratios show for Alterity Therapeutics Limited (PBN) stock - Market Risk Report & Long-Term Growth Stock Strategies newser.com Mon, 29 Sep 2025 13:32:23 GMT
• How Alterity Therapeutics Limited (PBN) stock trades after earnings - Weekly Trend Summary & AI Enhanced Market Trend Forecasts newser.com Mon, 29 Sep 2025 11:15:33 GMT
• Alterity Therapeutics targets major market with ATH434 in Multiple System Atrophy Biotech Dispatch Mon, 29 Sep 2025 10:33:37 GMT
• Can Alterity Therapeutics Limited (PBN) stock sustain institutional flows - July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts newser.com Mon, 29 Sep 2025 09:19:38 GMT
• Alterity Therapeutics Projects $2.4 Billion Sales for MSA Drug ATH434 TipRanks Mon, 29 Sep 2025 05:00:16 GMT
• Is Alterity Therapeutics Limited (PBN) stock good for wealth creation - Earnings Overview Report & Growth Focused Entry Point Repo... newser.com Sat, 27 Sep 2025 22:07:58 GMT
• is alterity therapeutics limited common stock pbn0 a good long term investment earlytimes.in Sat, 27 Sep 2025 21:22:29 GMT
• what analysts say about alterity therapeutics limited common stock pbn0 stock - earnings growth projections & explosive growth tra... Early Times Sat, 27 Sep 2025 14:38:04 GMT
• How Alterity Therapeutics Limited (Common Stock) (PBN0) stock compares with market leaders - Quarterly Market Summary & Low Risk H... newser.com Sat, 27 Sep 2025 05:19:26 GMT
• is alterity therapeutics limited pbn a good long term investment - insider buying signals & predict volatility with our neural net... Early Times Sat, 27 Sep 2025 03:25:50 GMT
• What valuation ratios show for Alterity Therapeutics Limited (PBN) stock - 2025 Trade Ideas & AI Based Buy/Sell Signal Reports newser.com Fri, 26 Sep 2025 17:08:51 GMT
• Will Alterity Therapeutics Limited (PBN) stock profit from AI boom - July 2025 PostEarnings & Verified Trade Idea Suggestions newser.com Fri, 26 Sep 2025 16:41:18 GMT
• how alterity therapeutics limited (pbn) stock trades after earnings - quarterly profit report & free safe capital growth stock tip... newser.com Fri, 26 Sep 2025 16:20:38 GMT
• can alterity therapeutics limited (pbn) stock sustain institutional flows - 2025 earnings impact & expert approved momentum trade ... newser.com Fri, 26 Sep 2025 16:20:13 GMT
• alterity therapeutics sets agm and director nomination dates TipRanks Tue, 23 Sep 2025 12:30:07 GMT
• alterity therapeutics raises a$20 million in strategic placement MSN Thu, 18 Sep 2025 13:56:06 GMT
• alterity therapeutics announces cessation of 35 million securities TipRanks Wed, 17 Sep 2025 03:40:55 GMT
• ‘tough nut to crack’, but expert tips alterity’s msa drug as potential game changer NT News Tue, 16 Sep 2025 09:18:10 GMT
• Alterity Therapeutics Announces Cessation of 35 Million Securities TipRanks Tue, 16 Sep 2025 07:00:00 GMT
• most active stocks: us stocks with the highest trading volume today au.finance.yahoo.com Tue, 16 Sep 2025 04:58:47 GMT
• alterity therapeutics presents ath434-201 phase 2 data at the american neurological association annual meeting GlobeNewswire Tue, 16 Sep 2025 01:28:30 GMT
• ‘Tough nut to crack’, but expert tips Alterity’s MSA drug as potential game changer Stockhead Mon, 15 Sep 2025 20:45:35 GMT
• alterity therapeutics (athe) reports promising phase 2 trial results for ath434 GuruFocus Mon, 15 Sep 2025 11:57:12 GMT
• Disease-Modifying Success: Alterity's ATH434 Drug Shows Meaningful Efficacy in Rare Brain Disease Trial Stock Titan Mon, 15 Sep 2025 07:00:00 GMT
• Alterity Therapeutics delivers promising Phase 2 data in Multiple System Atrophy Biotech Dispatch Mon, 15 Sep 2025 07:00:00 GMT
• alterity therapeutics’ ath434 shows promise in phase 2 msa trial TipRanks Mon, 15 Sep 2025 03:32:55 GMT
• alterity therapeutics announces quotation of new securities on asx TipRanks Mon, 15 Sep 2025 01:12:54 GMT
• Alterity Therapeutics Announces Quotation of New Securities on ASX TipRanks Sun, 14 Sep 2025 07:00:00 GMT
• Alterity Therapeutics’ ATH434 Shows Promise in Phase 2 MSA Trial TipRanks Sun, 14 Sep 2025 07:00:00 GMT
• alterity therapeutics raises a$20 million in strategic placement MSN Thu, 11 Sep 2025 09:42:23 GMT
• Alterity Therapeutics Raises A$20.0 million in Strategic Placement GlobeNewswire Mon, 08 Sep 2025 07:00:00 GMT
• Neurodegenerative Drug Developer Alterity Raises A$20M After Promising Multiple System Atrophy Results Stock Titan Mon, 08 Sep 2025 07:00:00 GMT
• Alterity Therapeutics secures $20 million to advance neurodegenerative disease pipeline Biotech Dispatch Mon, 08 Sep 2025 07:00:00 GMT
• Rockford Register Star: Local News, Politics & Sports in Rockford, IL FinancialContent Mon, 08 Sep 2025 07:00:00 GMT
• Multiple System Atrophy Clinical Trials Analysis, 2025 | MSA Companies Include Theravance Biopharma, H. Lundbeck A/S, Yoda Pharmac... Barchart.com Mon, 08 Sep 2025 07:00:00 GMT
• Alterity Therapeutics Secures A$20 Million in Strategic Placement Finance News Network Mon, 08 Sep 2025 07:00:00 GMT
• Break it Down: Funding boost for Alterity’s MSA drug candidate Stockhead Mon, 08 Sep 2025 07:00:00 GMT
• alterity therapeutics secures a$20 million to advance neurodegenerative disease treatment TipRanks Mon, 08 Sep 2025 03:09:23 GMT
• Alterity Therapeutics Secures A$20 Million to Advance Neurodegenerative Disease Treatment TipRanks Sun, 07 Sep 2025 07:00:00 GMT
• Alterity Therapeutics Initiates Trading Halt for Capital Raising TipRanks Thu, 04 Sep 2025 07:00:00 GMT
• alterity therapeutics shares rise 3.30% intraday after ceo to present at biotech showcase. AInvest Tue, 02 Sep 2025 17:12:21 GMT
• alterity therapeutics to present at biotech showcase, faces regulatory risks and financing challenges. AInvest Tue, 02 Sep 2025 11:28:42 GMT
• Alterity Therapeutics to Present at the Biotech Showcase GlobeNewswire Tue, 02 Sep 2025 07:00:00 GMT
• Neurodegenerative Disease Biotech Alterity Therapeutics Sets Corporate Update at Global Showcase Stock Titan Tue, 02 Sep 2025 07:00:00 GMT
• alterity therapeutics to present corporate update at biotech showcase TipRanks Mon, 01 Sep 2025 03:31:34 GMT
• alterity therapeutics releases 2025 corporate governance statement MSN Mon, 01 Sep 2025 00:05:34 GMT
• Alterity Therapeutics to Present Corporate Update at Biotech Showcase TipRanks Sun, 31 Aug 2025 07:00:00 GMT
• We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth simplywall.st Sun, 31 Aug 2025 07:00:00 GMT
• alterity therapeutics releases 2025 corporate governance statement The Globe and Mail Sat, 30 Aug 2025 07:00:00 GMT
• alterity therapeutics releases corporate governance statement for fy2025 The Globe and Mail Sat, 30 Aug 2025 05:02:00 GMT
• alterity therapeutics releases 2025 corporate governance statement TipRanks Fri, 29 Aug 2025 04:49:52 GMT
• alterity therapeutics releases corporate governance statement for fy2025 TipRanks Fri, 29 Aug 2025 04:49:07 GMT
• alterity therapeutics reports revenue growth amid financial loss TipRanks Fri, 29 Aug 2025 04:13:59 GMT
• Alterity Therapeutics Releases 2025 Corporate Governance Statement TipRanks Thu, 28 Aug 2025 07:00:00 GMT
• Alterity Therapeutics Releases Corporate Governance Statement for FY2025 TipRanks Thu, 28 Aug 2025 07:00:00 GMT
• alterity therapeutics reports revenue growth amid financial loss TipRanks Thu, 28 Aug 2025 07:00:00 GMT
• alterity therapeutics issues new unlisted options as part of employee incentive scheme MSN Sun, 24 Aug 2025 07:37:48 GMT
• alterity therapeutics announces quotation of new securities on asx TipRanks Fri, 22 Aug 2025 05:00:41 GMT
• alterity therapeutics announces quotation of new securities on asx TipRanks Thu, 21 Aug 2025 07:00:00 GMT
• alterity therapeutics limited (athe) announces positive topline data from phase 2 trial of ath434 in multiple system atrophy MSN Tue, 19 Aug 2025 01:27:38 GMT
• alterity therapeutics issues new unlisted options as part of employee incentive scheme MSN Mon, 18 Aug 2025 01:16:51 GMT
• alterity therapeutics limited (athe) announces positive topline data from phase 2 trial of ath434 in multiple system atrophy Insider Monkey Sun, 17 Aug 2025 05:57:41 GMT
• alterity therapeutics limited (athe) announces positive topline data from phase 2 trial of ath434 in multiple system atrophy Yahoo Finance Sat, 16 Aug 2025 07:00:00 GMT
• alterity therapeutics issues new unlisted options as part of employee incentive scheme TipRanks Fri, 15 Aug 2025 05:10:52 GMT
• alterity therapeutics issues new unlisted options as part of employee incentive scheme TipRanks Thu, 14 Aug 2025 07:00:00 GMT
• multiple system atrophy clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline | theravance ... Barchart.com Mon, 11 Aug 2025 07:00:00 GMT
• Alterity develops novel MRI biomarker to track disease progression in MSA BioWorld MedTech Tue, 05 Aug 2025 07:00:00 GMT
• alterity therapeutics publishes key neuroimaging measure for msa TipRanks Mon, 04 Aug 2025 04:18:52 GMT
• alterity therapeutics publishes key neuroimaging measure for msa TipRanks Sun, 03 Aug 2025 07:00:00 GMT
• buy rating for alterity therapeutics: promising phase 2 results and investment opportunity amid stock price dip TipRanks Fri, 01 Aug 2025 01:21:46 GMT
• alterity therapeutics advances msa treatment with fda fast track designation MSN Thu, 31 Jul 2025 19:19:48 GMT
• asx health quarterly wrap: control bionics makes 15pc sales revenue jump Stockhead Thu, 31 Jul 2025 07:00:00 GMT
• alterity develops novel mri biomarker to track disease progression in msa BioWorld MedTech Thu, 31 Jul 2025 07:00:00 GMT
• alterity therapeutics issues corporate presentation with forward-looking statements TipRanks Thu, 31 Jul 2025 01:03:06 GMT
• alterity therapeutics reports cash balance of a$40.66m as of june 30 TipRanks Wed, 30 Jul 2025 14:07:39 GMT
• alterity therapeutics issues corporate presentation with forward-looking statements TipRanks Wed, 30 Jul 2025 07:00:00 GMT
• alterity therapeutics advances msa treatment with fda fast track designation The Globe and Mail Wed, 30 Jul 2025 07:00:00 GMT
• alterity's msa treatment shows 48% disease reduction, earns fda fast track status in major breakthrough Stock Titan Wed, 30 Jul 2025 07:00:00 GMT
• athe: a tale of ups & downs – 63.16% gain in 6 months, 42.35% in 30 days investchronicle.com Tue, 29 Jul 2025 16:02:57 GMT
• Alterity Therapeutics reports positive topline data from Phase 2 trial of ATH434 Biotech Dispatch Tue, 29 Jul 2025 07:00:00 GMT
• alterity therapeutics advances msa treatment with fda fast track designation TipRanks Tue, 29 Jul 2025 07:00:00 GMT
• buy rating for alterity therapeutics: promising phase 2 results and investment opportunity amid stock price dip TipRanks Tue, 29 Jul 2025 07:00:00 GMT
• Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy Yahoo Finance Mon, 28 Jul 2025 07:00:00 GMT
• ATH434 Continues to Demonstrate Positive Efficacy in Latest Phase 2 Data Readout Neurology Live Mon, 28 Jul 2025 07:00:00 GMT
• Alterity reports data from multiple system atrophy study (ATHE) Seeking Alpha Mon, 28 Jul 2025 07:00:00 GMT
• Alterity Therapeutics Confirms Effectiveness of ATH434 Drug Against Advanced MSA smallcaps.com.au Mon, 28 Jul 2025 07:00:00 GMT
• Alterity Therapeutics Announces Positive Results from ATH434 Phase 2 Trial in Multiple System Atrophy Sharecafe Mon, 28 Jul 2025 07:00:00 GMT
• breakthrough: new drug cuts multiple system atrophy progression by 50% in phase 2 trial Stock Titan Mon, 28 Jul 2025 07:00:00 GMT
• alterity therapeutics shares rise 9.77% premarket after reporting positive topline data from phase 2 clinical trial of ath434. AInvest Mon, 28 Jul 2025 07:00:00 GMT
• alterity therapeutics reports topline data from open-label phase 2 ath434 trial TipRanks Mon, 28 Jul 2025 07:00:00 GMT
• alterity reports positive results from open-label phase ii trial of neurological disease drug Gold Coast Bulletin Mon, 28 Jul 2025 03:28:07 GMT
• alterity therapeutics reports promising phase 2 results for msa treatment TipRanks Mon, 28 Jul 2025 02:32:14 GMT
• Alterity Therapeutics Reports Promising Phase 2 Results for MSA Treatment TipRanks Sun, 27 Jul 2025 07:00:00 GMT
• alterity therapeutics confirms effectiveness of ath434 drug against advanced msa TradingView Sun, 27 Jul 2025 07:00:00 GMT
• alterity therapeutics announces publication on mri endpoint from biomuse study TipRanks Sat, 26 Jul 2025 23:54:49 GMT
• study backs alterity’s innovative tool in diagnosing and monitoring msa disease progression MSN Fri, 25 Jul 2025 18:01:47 GMT
• alterity skyrocketed 19.19%—can this neuroimaging breakthrough reshape biotech? AInvest Fri, 25 Jul 2025 07:00:00 GMT
• alterity therapeutics announces publication on mri endpoint from biomuse study TipRanks Thu, 24 Jul 2025 12:19:54 GMT
• study backs alterity’s innovative tool in diagnosing and monitoring msa disease progression MSN Thu, 24 Jul 2025 10:19:54 GMT
• Revolutionary AI-Based Brain Imaging Method Shows 100% Accuracy in Multiple System Atrophy Detection Stock Titan Thu, 24 Jul 2025 07:00:00 GMT
• Alterity Therapeutics Announces Publication on Novel MRI Endpoint for Multiple System Atrophy Sharecafe Thu, 24 Jul 2025 07:00:00 GMT
• alterity therapeutics unveils new mri endpoint for msa diagnosis and progression TipRanks Thu, 24 Jul 2025 02:18:52 GMT
• alterity therapeutics unveils new mri endpoint for msa diagnosis and progression TipRanks Wed, 23 Jul 2025 07:00:00 GMT
• alterity therapeutics expands market presence with new securities quotation The Globe and Mail Tue, 22 Jul 2025 02:32:00 GMT
• alterity therapeutics expands market presence with new securities quotation TipRanks Mon, 21 Jul 2025 02:33:19 GMT
• alterity therapeutics expands market presence with new securities quotation TipRanks Sun, 20 Jul 2025 07:00:00 GMT
• alterity therapeutics announces quotation of new securities on asx TipRanks Thu, 17 Jul 2025 04:20:57 GMT
• alterity therapeutics announces quotation of new securities on asx TipRanks Wed, 16 Jul 2025 07:00:00 GMT
• multiple system atrophy clinical trials 2025: ema, pdma, fda approvals, medication, therapies, treatment market, mechanism of acti... The Globe and Mail Mon, 14 Jul 2025 21:52:30 GMT
• alterity therapeutics addresses asx price query amid market anticipation TipRanks Mon, 14 Jul 2025 00:23:36 GMT
• alterity therapeutics addresses asx price query amid market anticipation TipRanks Sun, 13 Jul 2025 07:00:00 GMT
• Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket Benzinga Fri, 11 Jul 2025 07:00:00 GMT
• alterity therapeutics soars 18%—what’s fueling the neurodegenerative breakthrough? AInvest Fri, 11 Jul 2025 07:00:00 GMT
• alterity therapeutics (athe) shares soar 17.99% on fda fast track designation AInvest Fri, 11 Jul 2025 07:00:00 GMT
• multiple system atrophy pipeline 2025: latest fda approvals, openPR.com Thu, 10 Jul 2025 15:50:00 GMT
• alterity therapeutics announces change in substantial holding by bnymc AInvest Mon, 07 Jul 2025 07:00:00 GMT
• alterity therapeutics issues 15 million unlisted options to employees The Globe and Mail Thu, 03 Jul 2025 07:00:00 GMT
• alterity therapeutics stock doubles premarket on positive msa trial results: retail excitement soars Stocktwits Wed, 02 Jul 2025 07:00:00 GMT
• alterity therapeutics issues 15 million unlisted options to employees TipRanks Wed, 02 Jul 2025 07:00:00 GMT
• alterity therapeutics announces cessation of securities due to unmet conditions TipRanks Mon, 30 Jun 2025 07:00:00 GMT
• alterity therapeutics to update on ath434 progress in upcoming fireside chat TipRanks Tue, 24 Jun 2025 07:05:12 GMT
• alterity therapeutics to discuss ath434 development progress in fireside chat AInvest Tue, 24 Jun 2025 07:00:00 GMT
• Alterity Therapeutics to Provide Corporate Update in Fireside Chat TradingView Mon, 23 Jun 2025 07:00:00 GMT
• rockford register star: local news, politics & sports in rockford, il FinancialContent Mon, 23 Jun 2025 07:00:00 GMT
• alterity ceo to provide corporate update on ath434 development Investing.com Mon, 23 Jun 2025 07:00:00 GMT
• alterity therapeutics to update on ath434 progress in upcoming fireside chat TipRanks Sun, 22 Jun 2025 07:00:00 GMT
• alterity therapeutics granted u.s. fda fast track designation for ath434 to treat multiple system atrophy ADVFN Logo Fri, 13 Jun 2025 07:00:00 GMT
• alterity therapeutics granted u.s. fda fast track designation for ath434 to treat multiple system atrophy Revista ADVFN Wed, 11 Jun 2025 07:29:51 GMT
• alterity therapeutics presents encouraging new data from its ath434 phase 2 trial in multiple system atrophy at the american acade... mx.advfn.com Wed, 11 Jun 2025 03:58:20 GMT
• athe - alterity therapeutics prominently featured at the international msa congress mx.advfn.com Wed, 11 Jun 2025 03:57:19 GMT
• alterity therapeutics presents ath434-201 phase 2 clinical trial results at european msa symposium ADVFN Logo Wed, 11 Jun 2025 03:54:53 GMT
• financial review: talphera (nasdaq:tlph) & alterity therapeutics (nasdaq:athe) Defense World Thu, 29 May 2025 14:52:53 GMT
• is alterity therapeutics limited (athe) the best australian stock to buy according to analysts? Insider Monkey Thu, 15 May 2025 07:00:00 GMT
• 11 best australian stocks to buy according to analysts Insider Monkey Thu, 15 May 2025 04:29:02 GMT
• 11 best australian stocks to buy according to analysts Insider Monkey Wed, 14 May 2025 07:00:00 GMT
• alterity therapeutics (athe) showcases advancements at internati GuruFocus Tue, 13 May 2025 07:10:01 GMT
• athe showcases msa clinical programs at 2025 international confe GuruFocus Mon, 12 May 2025 13:28:47 GMT
• alterity therapeutics has several presentations featured at 2025 msa congress TipRanks Mon, 12 May 2025 13:07:11 GMT
• alterity therapeutics (athe) showcases advancements at internati GuruFocus Mon, 12 May 2025 13:01:33 GMT
• alterity therapeutics prominently featured at the international msa congress GlobeNewswire Mon, 12 May 2025 07:00:00 GMT
• alterity therapeutics showcases promising msa treatment advances TipRanks Mon, 12 May 2025 01:29:31 GMT
• alterity therapeutics showcases promising msa treatment advances TipRanks Sun, 11 May 2025 07:00:00 GMT
• jpmorgan chase & co. acquires significant stake in alterity ther GuruFocus Fri, 09 May 2025 00:42:38 GMT
• jpmorgan chase & co. acquires significant stake in alterity therapeutics ltd GuruFocus Thu, 08 May 2025 07:00:00 GMT
• alterity therapeutics (athe) receives fda fast track designation for msa treatment | athe stock news GuruFocus Wed, 07 May 2025 21:37:07 GMT
• FDA grants fast track status to Alterity’s multiple system atrophy treatment Pharmaceutical Business review - Wed, 07 May 2025 07:00:00 GMT
• alterity therapeutics announces multiple oral and poster GlobeNewswire Wed, 07 May 2025 07:00:00 GMT
• alterity therapeutics reports phase 2 data at msa congress Investing.com Wed, 07 May 2025 07:00:00 GMT
• alterity therapeutics to showcase msa research at 2025 congress TipRanks Wed, 07 May 2025 03:19:53 GMT
• alterity therapeutics granted u.s. fda fast track designation for ath434 TipRanks Tue, 06 May 2025 07:14:33 GMT
• alterity therapeutics to showcase msa research at 2025 congress TipRanks Tue, 06 May 2025 07:00:00 GMT
• alterity awaits trial results for drug to treat neurodegenerative disease, stock up 255% in 2 months RTTNews Tue, 06 May 2025 07:00:00 GMT
• alterity therapeutics (athe) gains fda fast track status for msa treatment | athe stock news GuruFocus Mon, 05 May 2025 12:11:49 GMT
• Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy GlobeNewswire Mon, 05 May 2025 07:00:00 GMT
• Breakthrough: FDA Fast-Tracks Novel MSA Drug ATH434 - First Potential Treatment for Fatal Brain Disease Stock Titan Mon, 05 May 2025 07:00:00 GMT
• FDA grants fast track designation for Alterity's ATH434 to treat multiple system atrophy Biotech Dispatch Mon, 05 May 2025 07:00:00 GMT
• health check: biotechs recover as peace descends on the fda – for now Stockhead Mon, 05 May 2025 07:00:00 GMT
• monday’s hotcopper trends: | alterity's fda tick, gold road snapped up | may 5, 2025 MSN Mon, 05 May 2025 07:00:00 GMT
• alterity therapeutics granted us fda fast track designation for lead candidate to treat multiple system atrophy marketscreener.com Mon, 05 May 2025 07:00:00 GMT
• alterity therapeutics receives us fda fast track designation; shares up 11% marketscreener.com Mon, 05 May 2025 01:36:08 GMT
• alterity therapeutics announces granting of u.s. fda fast track designation for ath434 marketscreener.com Mon, 05 May 2025 01:31:02 GMT
• alterity therapeutics’ ath434 receives fda fast track designation for msa treatment TipRanks Mon, 05 May 2025 00:12:27 GMT
• alterity therapeutics’ ath434 receives fda fast track designation for msa treatment TipRanks Sun, 04 May 2025 07:00:00 GMT
• alterity therapeutics receives us fda fast track designation; shares up 11% MarketScreener Sun, 04 May 2025 07:00:00 GMT
• athe - alterity therapeutics ltd latest stock news & market updates Stock Titan Fri, 02 May 2025 23:13:23 GMT
• alterity therapeutics (athe) advances ath434 development amid strong financial performance | athe stock news GuruFocus Wed, 30 Apr 2025 12:20:45 GMT
• alterity therapeutics reports positive phase 2 trial results for msa treatment TipRanks Wed, 30 Apr 2025 07:00:00 GMT
• breakthrough: ath434 clinical trial reveals 48% disease reduction in untreated neurological disorder Stock Titan Wed, 30 Apr 2025 07:00:00 GMT
• appendix 4c -- q3 fy25 quarterly cash flow report | athe stock news GuruFocus Wed, 30 Apr 2025 07:00:00 GMT
• alterity therapeutics reports cash balance of a$17.96m as of march 31 TipRanks Wed, 30 Apr 2025 07:00:00 GMT
• alterity therapeutics announces director securities changes TipRanks Tue, 29 Apr 2025 07:00:00 GMT
• alterity presents ath434-201 phase 2 trial results at msa symposium TipRanks Mon, 28 Apr 2025 16:15:45 GMT
• alterity therapeutics (athe) reports promising phase 2 trial res GuruFocus Mon, 28 Apr 2025 13:07:30 GMT
• Breakthrough: Alterity's MSA Treatment Achieves 48% Efficacy Rate in Phase 2 Clinical Trial Stock Titan Mon, 28 Apr 2025 07:00:00 GMT
• alterity therapeutics presents ath434-201 phase 2 clinical trial results at european msa symposium GlobeNewswire Mon, 28 Apr 2025 07:00:00 GMT
• alterity therapeutics reports positive phase 2 trial results for msa treatment TipRanks Mon, 28 Apr 2025 04:20:13 GMT
• alterity therapeutics reports positive phase 2 trial results for msa treatment TipRanks Sun, 27 Apr 2025 07:00:00 GMT
• athe - alterity therapeutics ltd latest stock news & market updates Stock Titan Thu, 24 Apr 2025 18:03:24 GMT
• alterity therapeutics issues caution on forward-looking statements TipRanks Tue, 22 Apr 2025 00:28:02 GMT
• alterity therapeutics issues caution on forward-looking statements TipRanks Mon, 21 Apr 2025 07:00:00 GMT
• alterity therapeutics announces new options prospectus to bolster financial strategy TipRanks Thu, 17 Apr 2025 04:06:13 GMT
• alterity therapeutics announces new options prospectus to bolster financial strategy TipRanks Wed, 16 Apr 2025 07:00:00 GMT
• alterity therapeutics presents encouraging new data from its ath GuruFocus Fri, 11 Apr 2025 08:26:35 GMT
• promising phase 2 results and technological integration justify buy rating for alterity therapeutics TipRanks Fri, 11 Apr 2025 07:00:00 GMT
• alterity therapeutics (athe) shows promising results in msa trea GuruFocus Fri, 11 Apr 2025 06:51:09 GMT
• alterity therapeutics reports new data from ath434 phase 2 trial at aan meeting TipRanks Thu, 10 Apr 2025 11:48:27 GMT
• Breakthrough MSA Treatment Achieves 48% Disease Slowdown in Phase 2 Trial Stock Titan Thu, 10 Apr 2025 07:00:00 GMT
• alterity therapeutics presents encouraging new data from its ath434 phase 2 trial in multiple system atrophy at the american acade... GlobeNewswire Thu, 10 Apr 2025 07:00:00 GMT
• alterity therapeutics (athe) shows promising results in msa trea GuruFocus Thu, 10 Apr 2025 07:00:00 GMT
• alterity therapeutics unveils promising phase 2 study results for msa treatment TipRanks Thu, 10 Apr 2025 04:14:58 GMT
Alterity Therapeutics Limited(NASDAQ:ATHE) 
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinsonian's disease and other neurodegenerative diseases in Australia. The company's lead drug candidates is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It i...
Website: http://www.alteritytherapeutics.com
Founded: 1997
CEO: David Stamler
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends